| Results summary | View all lists in GO:BiolProc | View all genes in D07A.profile.ud50 |
|
The cascade of processes by which a signal interacts with a receptor, causing a change in the level or activity of a second messenger or other downstream target, and ultimately effecting a change in the functioning of the cell. enrichment: 1.78-fold |
![]() |
||||||||||||
| Probe ID | Name | G | T | D | X | E | P | R | C | S | Description | ||
| 202973_X_AT | FAM13A1 | S | family with sequence similarity 13, member A1 | ||||||||||
| 211959_AT | IGFBP5 | S | insulin-like growth factor binding protein 5 | ||||||||||
| 210367_S_AT | PTGES | E | S | prostaglandin E synthase | |||||||||
| 201939_AT | PLK2 | P | S | polo-like kinase 2 (Drosophila) | |||||||||
| 215073_S_AT | NR2F2 | D | E | R | S | nuclear receptor subfamily 2, group F, member 2 | |||||||
| 216250_S_AT | LPXN | P | C | S | leupaxin | ||||||||
| 212669_AT | CAMK2G | T | P | C | S | calcium/calmodulin-dependent protein kinase (CaM kinase) II gamma | |||||||
| 203372_S_AT | SOCS2 | G | S | suppressor of cytokine signaling 2 | |||||||||
| 203140_AT | BCL6 | G | D | X | R | C | S | B-cell CLL/lymphoma 6 (zinc finger protein 51) | |||||
| 203543_S_AT | KLF9 | D | R | S | Kruppel-like factor 9 | ||||||||
| 208078_S_AT | SNF1LK | D | P | S | SNF1-like kinase | ||||||||
| 205440_S_AT | NPY1R | E | S | neuropeptide Y receptor Y1 | |||||||||
| 202861_AT | PER1 | R | S | period homolog 1 (Drosophila) | |||||||||
| 206114_AT | EPHA4 | P | S | EPH receptor A4 | |||||||||
| 204526_S_AT | TBC1D8 | G | S | TBC1 domain family, member 8 (with GRAM domain) | |||||||||
| 211668_S_AT | PLAU | X | P | S | plasminogen activator, urokinase | ||||||||
| 203438_AT | STC2 | C | S | stanniocalcin 2 | |||||||||
| 209357_AT | CITED2 | D | R | S | Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 | ||||||||
| 205945_AT | IL6R | G | D | X | S | interleukin 6 receptor | |||||||
| 215990_S_AT | BCL6 | G | D | X | R | C | S | B-cell CLL/lymphoma 6 (zinc finger protein 51) | |||||
| 209185_S_AT | IRS2 | G | D | E | S | insulin receptor substrate 2 | |||||||
| 203373_AT | SOCS2 | G | S | suppressor of cytokine signaling 2 | |||||||||
| 207980_S_AT | CITED2 | D | R | S | Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 | ||||||||
| 203542_S_AT | KLF9 | D | R | S | Kruppel-like factor 9 | ||||||||
| 203108_AT | GPRC5A | S | G protein-coupled receptor, family C, group 5, member A | ||||||||||
| 36829_AT | PER1 | R | S | period homolog 1 (Drosophila) | |||||||||
| 202670_AT | MAP2K1 | P | S | mitogen-activated protein kinase kinase 1 | |||||||||
| 200878_AT | EPAS1 | D | X | R | S | endothelial PAS domain protein 1 | |||||||
| 209121_X_AT | NR2F2 | D | E | R | S | nuclear receptor subfamily 2, group F, member 2 | |||||||
| 205486_AT | TESK2 | G | P | C | S | testis-specific kinase 2 | |||||||
| 201976_S_AT | MYO10 | S | myosin X | ||||||||||
| 205479_S_AT | PLAU | X | P | S | plasminogen activator, urokinase | ||||||||
| 201502_S_AT | NFKBIA | G | T | D | S | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | |||||||
| 204924_AT | TLR2 | G | X | S | toll-like receptor 2 | ||||||||
| 205067_AT | IL1B | G | X | P | C | S | interleukin 1, beta | ||||||
| 209184_S_AT | IRS2 | G | D | E | S | insulin receptor substrate 2 | |||||||
| 39402_AT | IL1B | G | X | P | C | S | interleukin 1, beta | ||||||